The functional α-adrenoceptor in dog caudal vesical arteries is mainly an αIA subtype

Autonomic and Autacoid Pharmacology

Volumn 22, Issue 5-6, 2002, Pages 253-259

  Nakazawa, M ^a   Taguchi, Y ^a   Yang, X P ^a   Chiba, S ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

adrenoceptor subtype; Cannula inserting method; Caudal vesical artery; Prazosin; WB4101

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR; CHLOROETHYLCLONIDINE; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RAUWOLSCINE; RECEPTOR SUBTYPE; XYLAZINE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DRUG INHIBITION; FEMALE; ISOLATED ARTERY; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARTERIES; BLOOD PRESSURE; CLONIDINE; DIOXANES; DOGS; FEMALE; MALE; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PHENYLEPHRINE; PIPERAZINES; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; REGIONAL BLOOD FLOW; URINARY BLADDER; XYLAZINE; YOHIMBINE;

EID: 0042123609     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1474-8673.2002.00267.x     Document Type: Article

References (37)

1. 1L-adrenoceptor mediates contraction of canine subcutaneous resistance arteries. J. Pharmacol. Exp. ther., 295, 627-633.
2. CAMPOS, V.J., PINTO, S.P., MELLO, D.S. & ORSI, A.M. (1985). The vesical medial artery, Rauch 1963, of the dog (Canis familiaris). Anat. Anz., 160, 59-63.
3. CHIBA, S. & TSUKADA, M. (1984). Vasoconstrictor responses of isolated and perfused canine mesenteric arteries to α-adrenoceptor agonists. Arch. Int. Pharmacodyn. ther., 271, 241-248.
4. 1-Adrenoceptors in canine mesenteric artery are predominantly 1A subtype: pharmacological and immunochemical evidence. J. Pharmacol. Exp. ther., 291, 671-679.
5. 1L-adrenoceptor subtype in the lower urinary tract: a comparison of human urethra and prostate. Br. J. Urol., 82, 733-737.
6. 1-adrenoceptors. Eur. J. Pharmacol., 272, R5-R6.
7. GUIMARAES, S. & MOURA, D. (2001). Vascular adrenoceptors: an update. Pharmacol. Rev., 53, 319-356.
8. 2+ in smooth muscle. Nature, 333-335.
9. 1-adrenoceptors consensus update. Pharmacol. Rev., 47, 267-270.
10. HONGO, K. & CHIBA, S. (1983). A new method for measuring vascular responsiveness of relatively larger arteries of dogs. J. Pharmacol. Meth., 9, 83-91.
11. ITO, T. & CHIBA, S. (1984). Vascular responses of isolated canine intermediate auricular artery to vasoactive substances. Arch. Int. Pharmacodyn. ther., 268, 225-231.
12. ITO, T. & CHIBA, S. (1985). Existence of two types of postjunctional alpha adrenoceptors in the isolated canine intermediate auricular artery. J. Pharmacol. Exp. ther., 234, 698-702.
13. 1-adrenoceptor subtypes in human skeletal muscle resistance arteries. Br. J. Pharmacol., 133, 679-686.
14. 1L-Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man. Br. J. Pharmacol., 123, 1359-1366.
15. 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br. J. Pharmacol., 115, 981-986.
16. 1-adrenoceptor subtypes involved in adrenergic contractions of dog blood vessels. Br. J. Pharmacol., 112, 1167-1173.
17. LEONARDI, A., HIEBLE, J.P., GUARNERI, L., NASELSKY, D.P., POGGESI, E., SIRONI, G., SULPIZIO, A.C. & TESTA, R. (1997). Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, Part I. J. Pharmacol. Exp. ther., 281, 1272-1283.
18. LOW, A.M., LU-CHAO, H., WANG, Y.F., BROWN, R.D., KWAN, C.Y. & DANIEL, E.E. (1998). Pharmacological and immunocytochemical characterization of subtypes of alpha-1 adrenoceptors in dog aorta. J. Pharmacol. Exp. ther., 285, 894-901.
19. MILLER, M.E., CHRISTENSEN, G.C. & EVANS, H.E. (1964). Anatomy of the Dog, pp. 380-381. Saunders, Philadelphia.
20. 1-Adrenergic receptor subtypes. Annu. Rev. Pharmacol. Toxicol., 34, 117-133.
21. 1-adrenergic receptor subtypes distinguished by chlorethylclonidine and WB4101. Mol. Pharmacol., 33, 509-514.
22. 3H]prazosin binding. Mol. Pharmacol., 29, 321-330.
23. 1-adrenoceptors in vascular smooth muscle. Br. J. Pharmacol., 99, 197-201.
24. 1-adrenoceptor subtypes in dog mesenteric and carotid arteries and rabbit carotid arteries. Br. J. Pharmacol., 102, 210-214.
25. NAKANE, T. & CHIBA, S. (1987). Postjunctional α-adrenoceptor subtypes in isolated and perfused canine epicardial coronary arteries. J. Cardiovasc. Pharmacol., 10, 651-657.
26. 1D adrenoceptor to the contraction of vascular smooth muscle. J. Pharmacol. Exp. ther., 275, 1583-1589.
27. REN, L.M., NAKANE, T. & CHIBA, S. (1994). Characteristics of the responses of isolated and perfused canine splenic arteries to vasoactive substances and to periarterially electrical stimulation. Jpn. J. Pharmacol., 64, 19-25.
28. SAUSSY, D.L. Jr, GOETZ, A.S., QUEEN, K.L., KING, H.K., LUTZ, M.W. & RIMELE, T.J. (1996). Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. J. Pharmacol. Exp. ther., 278, 136-144.
29. SCHWINN, D.A, JOHNSTON, G.I., PAGE, S.O. et al. (1995). Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J. Pharmacol. Exp. ther., 272, 134-142.
30. 1A-subtype. Eur. Urol., 36 (Suppl. 1), 7-10.
31. SKRBIC, R. & CHIBA, S. (1991). Pharmacological features of vascular responses of isolated dog and monkey lingual arteries to vasoactive substances. Jpn. J. Pharmacol., 57, 99-107.
32. 1-adrenoceptors. Heart Vessels, 7, 82-90.
33. 2+, signalling mechanism and plays a different physiological role. Mol. Pharmacol., 38, 725-736.
34. 1B-adrenoceptor subtypes in canine mandibular alveolar arteries. Clin. Exp. Pharmacol. Physiol., 28, 716-720.
35. TSUJI, T. & CHIBA, S. (1984). Potentiating effect of methysergide on norepinephrine induced constriction of the isolated internal carotid artery of the dog. Jpn. J. Pharmacol., 34, 95-100.
36. 1-adrenoceptor subtypes in junctional and extrajunctional neurovascular regions in canine splenic arteries. Br. J. Pharmacol., 132, 1852-1858.
37. YANG, M., REESE, J., COTECCHIA, S. & MICHEL, M.C. (1998). Murine alpha 1-adrenoceptor subtypes. I. Radioligand binding studies. J. Pharmacol. Exp. ther., 286, 841-847.